Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women.

@article{Hankinson1999PlasmaPL,
  title={Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women.},
  author={Susan E. Hankinson and Walter C Willett and Dominique S. Michaud and Joann E. Manson and Graham A. Colditz and Christopher Longcope and Bernard A Rosner and Frank E. Speizer},
  journal={Journal of the National Cancer Institute},
  year={1999},
  volume={91 7},
  pages={629-34}
}
BACKGROUND In animal studies, prolactin has been found to be important for mammary epithelial development and its administration has been shown consistently to increase the rate of mammary tumor formation. Previous epidemiologic studies of prolactin and breast cancer risk in postmenopausal women have been limited in size, and the results have been inconsistent. We conducted a nested case-control study within the prospective Nurses' Health Study cohort to better determine the relationship… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 126 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 62 references

Insulin - like growthfactorbinding protein 3 is decreased in early - stage operable premenopausal breast cancer [ published erratum appears

  • PF Bruning, J VanDoorn, JM Bonfrer
  • Int J Cancer
  • 1995

Insulinlike growth-factor-binding protein 3 is decreased in early-stage operable premenopausal breast cancer [published erratum appears in Int J Cancer 1995;63:762

  • PF Bruning, J Van Doorn, JM. Bonfrer
  • Int J Cancer
  • 1995

Measurement error in nonlinear models. London (U.K.)

  • RJ Carroll, D Ruppert, LA. Stefanski
  • 1995

Similar Papers

Loading similar papers…